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Liquid-Based Urine Cytology as a Tool for Detection of Human
Papillomavirus, Mycoplasma spp., and Ureaplasma spp. in Men
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Kazufumi Nakashima,c Keiichi Furubayashi,d and Mikio Namikia
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japana; Department of Reproductive and
Perinatal Medicine, Kanazawa Medical University, Kanazawa, Japanb; Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa, Japanc; and Sonezaki
Furubayashi Clinic, Osaka, Japand
Liquid-based urine cytology (LB-URC) was evaluated for cytological diagnosis and detection of human papillomavirus (HPV),
Mycoplasma, andUreaplasma. Midstream urine samples were collected from 141male patients with urethritis and 154 controls
without urethritis, and sediment cells were preserved in liquid-based cytology solution. Urethral swabs from urethritis patients
were tested for the presence ofNeisseria gonorrhoeae and Chlamydia trachomatis. Papanicolaou tests were performed for cyto-
logical evaluation. HPV,Mycoplasma, andUreaplasma genomes were determined by PCR-based methods, and localization of
HPVDNA in urothelial cells was examined by in situ hybridization (ISH). The -globin gene was positive in 97.9% of LB-URC
samples from urethritis patients and in 97.4% of control samples, suggesting that high-quality cellular DNAwas obtained from
the LB-URC samples. HPVDNAwas detected in 29 (21.0%) urethritis cases and in five (3.3%) controls (P< 0.05). HPV type 16
(HPV 16) was most commonly found in urethritis patients. Cytological evaluations could be performed for 92.1% of urethritis
patients and 64.3% of controls. Morphological changes suggestive of HPV infection were seen in 20.7% of the HPV-positive sam-
ples, and ISH demonstrated the presence of HPVDNA in both squamous and urothelial cells in HPV-positive samples.Myco-
plasma genitalium,Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum were detected in 14.5%, 10.9%,
6.5%, and 12.3% of urethritis patients, respectively. The prevalence rates of these microorganisms (exceptUreaplasma parvum)
were significantly higher in urethritis cases than controls (P< 0.05). LB-URC is applicable for detection of HPV,Mycoplasma,
andUreaplasma.HPV infection occurs in urothelial cells, especially in gonococcal urethritis.
Human papillomavirus (HPV) infection is known to causeuterine cervical cancer and precancerous lesions in women
(14, 29).HPV infection usually occurs through sexual intercourse,
and it has been reported that the prevalence of HPV infection in
sexually active healthy young women ranges from 20% to 60%
(12, 19, 26). Thus, cervical HPV infection is thought to be one of
the most common sexually transmitted infections (STIs) in
women.
Prophylactic HPV vaccine has become available worldwide to
prevent cervical cancer, and the prevalence and sites of HPV in-
fection in the male genital tract have been studied. Some studies
indicated that the external male genitalia, including the penile
shaft, glans, coronal sulcus, and prepuce, are the most common
sites of HPV infection and that the prevalence of HPV among
healthy youngmen is as high as that among healthy youngwomen
(9, 10). However, a systematic review indicated that the HPV de-
tection rate in urine was less than 7% and that urine is unsuitable
for HPV detection in epidemiological studies (9). Indeed, Giu-
liano et al examined the presence of HPVDNA inmultiple genital
sites of 186 healthymen and reported thatHPVwas detectedmost
commonly on the penile shaft (49.9%), followed by the glans
(35.8%), scrotum (34.2%), perianal area (20.0%), anal canal
(17.6%), urethra (10.1%), and semen (5.3%). The HPV detection
rate was the poorest in urine samples (0.8%) (10).
We have recently reported a high (24%) prevalence of HPV
infection in urine samples from 142 Japanese men with urethritis
(22). However, the -globin gene used as an internal control was
detected in only 65% of cases (n  92), and we considered that
poor quality of DNA or some inhibitory factors for PCRmay have
been associated with the failure of PCR tests in urine samples.
Urine samples are suitable for large-scale studies of not only HPV
but also othermicroorganisms that cause urethritis because of the
ease and noninvasive nature of sampling. Therefore, we have at-
tempted to improve the analysis methods using urine samples.
In the present study, we used liquid-based cytology (LBC)
samples of urine sediment to detect not only HPV DNA but also
DNA of other microorganisms, such as Mycoplasma spp. and
Ureaplasma spp. In addition, we evaluated the cytological findings
of urine sediment tests based on Papanicolaou staining and per-
formed in situ hybridization (ISH) analyses to confirm the local-
ization of HPV DNA in urothelial cells.
MATERIALS AND METHODS
Subjects. A total of 141 male patients with urethritis (urethritis group)
and 154 male patients without urethritis (controls) who visited the Urol-
ogy Department of Kanazawa University Hospital, Kanazawa, Japan, and
Ishikawa Prefectural Central Hospital, Kanazawa, Japan, and a sexually
transmitted disease (STD) clinic in Osaka, Japan, between April 2009 and
April 2010 were enrolled in this study. The control group consisted of
male patients with urinary stones, infertility, or hypogonadism. Subjects
with urogenital tumors or with histories of STD within the previous 12
months were excluded as controls. The clinical diagnosis of urethritis was
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based on microscopic detection of more than five white blood cells/high-
power field from urethral swabs and the presence of definite histories of
sexual intercourse with men or women. After obtaining written informed
consent, according to the protocol approved by the Ethics Committee of
KanazawaUniversityGraduate School ofMedicine, each patient provided
amidstreamurine specimen.Urine specimens (15ml)were centrifuged at
1,500 rpm for 10 min, and the sediment was placed into a separate tube
containing 2.5 ml of preservative solution for LBC (LiquiPrep; LGM In-
ternational Inc, Melbourne, FL) and stored at 4°C until testing.
The patients with definite genital lesions, such as condyloma acumi-
nata, were excluded. All patients with urethritis were tested for the pres-
ence of Neisseria gonorrhoeae and Chlamydia trachomatis in urethral
swabs, based on Amplicor STD-1 PCR (Roche Diagnostics, Basel, Swit-
zerland).
HPV DNA analysis and genotyping. Aliquots of 700 l of well-
agitated samples were centrifuged at 5,000 rpm for 5 min, and the super-
natants were discarded. The cell pellets werewashedwith 300l of 10mM
Tris-HCl buffer solution (pH 8.0). DNA was extracted using a DNA ex-
traction kit (SMI test; G&G Science Co, Fukushima, Japan). The-globin
gene was first amplified to confirm the adequacy of extracted DNA in all
samples. In -globin-positive samples, HPVDNAwas tested bymodified
GP5/GP6 PCR as described previously (22, 28).
In the HPV-positive samples, HPV genotyping was performed using
HPV GenoArray test kits (HybriBio Limited, Central Hong Kong, Hong
Kong) (22). This test is capable of detecting 21 HPV types, including 5
low-risk types (HPV 6, 11, 42, 43, and 44), 14 high-risk types (HPV 16, 18,
31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68), and 2 undetermined-risk
types (HPV 53 and HPV 81). Some samples that were positive on PCR
analysis and negative on the genotyping test were defined as representing
an unknown HPV type(s).
Cytological examinationbasedonPapanicolaou staining and in situ
hybridization. Aliquots of 700 l of each sample were subjected to mi-
crotube centrifugation at 5,000 rpm for 10min, and the supernatantswere
decanted. The residual cell pellets were mixed with 50 l of Cellular Base
Solution (LiquiPrep; LGM International Inc) and pipetted onto glass mi-
croscope slides. The slides were air dried for more than 60 min and then
subjected to Papanicolaou staining. All slides were randomly checked by a
cytopathologist certified by the Japanese Society of Clinical Cytology
without previous knowledge of the molecular findings. HPV infection-
associated morphological signs were judged based on the presence of the
two classic signs (koilocytosis and dyskeratocytosis) and the nine nonclas-
sic signs (mild koilocytosis,mild dyskeratocytosis, cleared cytoplasm, ker-
atohyalin granules, condensation of filaments, spindle cells, nuclear hy-
perchromatism, multinucleation, and perinuclear halos) described
previously by Schneider et al (21).
Furthermore, ISH was performed in all high-risk HPV-positive sam-
ples to determine the localization of HPVDNA in urothelial cells accord-
ing to the manufacturer’s instructions (Dako GenoPoint System [catalog
no. K0620]; Dako, Carpinteria, CA). After being fixed with 95% ethanol
for 60 min, the slides were placed into Target Retrieval Solution (catalog
no. S1700; Dako, Glostrup, Denmark) at 95°C for 40 min, followed by
digestion with proteinase K (catalog no. S3004; Dako) at room tempera-
ture for 10 min. Endogenous peroxidase was blocked with 0.3% H2O2 in
methanol for 20 min. Denatured DNA was hybridized with a wide-
spectrum biotinylated HPVDNA probe (catalog no. Y1404; Dako) for 13
high-risk HPV types (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and
68) at 90°C for 5 min. After hybridization with the HPV DNA probe in a
humid chamber at 37°C for 16 to 18 h, the slides were reacted with pri-
mary streptavidin-horseradish peroxidase (streptavidin-HRP), biotin
tyramide solution, and secondary streptavidin-HRP for 15 min each.
Then, a diaminobenzidine reaction was performed for 5 min. HPV DNA
signals were visualized as brown staining. All slides were counterstained
with hematoxylin. As controls, ISH was also performed in 10 HPV-
negative samples.
Analysis of Mycoplasma spp. and Ureaplasma spp. The detection
rates of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urea-
lyticum (biovar 2), and Ureaplasma parvum (biovar 1) were also investi-
gated bymultiplex PCRassay in samples positive for-globin as described
previously (25, 27). Primer pair MG1 andMG2, primer pair RNAH1 and
RNAH2, and primer pair UMS125 and UMA226 were used to identifyM.
genitalium (282 bp),M. hominis (334 bp), andU. parvum (403 bp) andU.
urealyticum (448 bp), respectively (27).
Statistical analysis. The 2 test was used compare the positive rates
determined for the two groups, and theMann-WhitneyU test was used to
compare the numbers between two groups. In all analyses, P 0.05 was
taken to indicate statistical significance.
RESULTS
HPV infection in urothelial cells.To investigate the usefulness of
liquid-based urine cytology (LB-URC), age-matched male pa-
tients with urethritis (37.6  9.2 years of age) and male patients
without urethritis as controls (39.0  9.8 years) participated in
this study. Of 141 patients with urethritis, 17 had gonococcal ure-
thritis (GU), 24 had nongonococcal chlamydial urethritis
(NGCU), and 100 had nongonococcal and nonchlamydial ure-
thritis (NGNCU). None of the patients showed mixed infections
with N. gonorrhea and C. trachomatis. None of the patients with
urethritis had histories of sexual intercourse with men.
The -globin gene was positive in 138 specimens (97.8%) of
LB-URC samples from the urethritis group and in 150 specimens
(97.4%) from the control group, and high -globin-positive rates
were observed in both groups (Table 1).HPVof any type andHPV
high-risk types were detected in 21.0% (n 29) and 13.0% (n
18) of urethritis patients, respectively. In contrast, HPV of any
type and HPV high-risk types were detected in 3.3% (n 5) and
0.7% (n 1) of controls, indicating a significantly higher preva-
lence of HPV in the urethritis patients than in the controls (P 
0.05) (Table 1). As shown in Table 2, HPV 16 was the most com-
mon type (n 6; 20.0%) in the urethritis group, followed byHPV
58 (n  4; 13.3%). High-risk HPV types, including HPV 16, 18,
31, 33, 39, 52, 58, 59, and 68, were detected in 67% of the HPV-
positive samples in urethritis patients. One low-risk HPV type
(HPV 6) and one undetermined-risk HPV type (HPV 66) were
detected in control patients. HPV of an unknown type was de-
tected in five (16.6%) urethritis patients and three (60%) controls.
Cytological findings using LB-URC samples could be evalu-
ated in 130 (92.1%) cases and 99 (64.3%) controls. Eleven urethri-
TABLE 1 Adequacy rates and detection rates of HPV,Mycoplasma spp.,
and Ureaplasma spp. in urine samples by liquid-based processinga
Gene or organism






-Globin gene 138 (97.9) 150 (97.4) 0.906
Any HPV type 29 (21.0) 5 (3.3) 0.001
High-risk HPV type 18 (13.0) 1 (0.7) 0.001
Low-risk HPV type 4 (2.9) 1 (0.7) 0.319
M. genitalium 20 (14.5) 5 (3.3) 0.002
M. hominis 15 (10.9) 3 (2.0) 0.004
U. parvum 9 (6.5) 7 (4.7) 0.668
U. urealyticum 17 (12.3) 4 (2.7) 0.003
a The ages (in years) of the members of the urethritis group ranged from 20 to 63
(37.6 9.2) (P 0.209); the ages (in years) of the members of the control group
ranged from 19 to 59 (39.0 9.8) (P 0.209). HPV, human papillomavirus.
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tis samples and 55 control samples could not be evaluated because
of the low quantity of cell samples. Of 29 HPV-positive samples
from urethritis patients, HPV infection-related morphological
changes, such as koilocytosis, dyskeratocytosis, and multinucle-
ation, were observed in six (20.7%) cases (Fig. 1). ISH analysis was
performed to clarify the localization of HPV DNA in the urothe-
lium. Only a limited number of samples could be evaluated, be-
cause the cells were lost from the slides during the antigen activa-
tion process. Only seven (36.8%) HPV-positive and three (30%)
HPV-negative samples could be evaluated. However, HPV DNA
signals were successfully observed in the nuclei of either squamous
cells or transitional cells in three HPV-positive samples (Fig. 2),
while no such signals were seen in the HPV-negative samples.
These findings suggested that HPV can infect both squamous cells
and urothelial cells in urethritis patients.
Mycoplasma spp. and Ureaplasma spp. as causes of urethri-
tis. M. genitalium, M. hominis, U. parvum, and U. urealyticum
were detected in 14.5%, 10.9%, 6.5%, and 12.3% of men with
urethritis, whereas the species were detected in 3.3%, 2.0%, 4.7%,
and 2.7% of controls, respectively (Table 1). M. genitalium, M.
hominis, U. parvum, and U. urealyticum were detected in 14.2%,
12.2%, 9.2%, and 11.2% of patients with NGNCU, respectively
(Table 3). The prevalence rates ofM. genitalium,M. hominis, and
U. urealyticum in men with NGNCU were significantly higher
than in the control group (P 0.05), suggesting that these micro-
organisms may cause urethritis independently. It was noted that
HPV was detected in 47.0% of GU but in 13.0% of NGCU and in
18.4%ofNGNCUpatients. The prevalence ofHPV inGUpatients
was significantly higher than in NGCU or NGNCU patients (P
0.05) (Table 3).
DISCUSSION
The present study demonstrated that LB-URC is a promising
method for molecular analysis of microorganisms in the urinary
tract. The results of the present study indicated that a high positive
rate of -globin could be obtained in LB-URC samples frommen
both with and without urethritis. Some previous studies have
demonstrated failure of amplification of DNA extracted from
urine sediment cells by PCR. Giuliano et al reported that the
-globin gene was detected in 51.3% of urine samples collected
from 226 healthy men and showed a low prevalence of HPV in-
fection (0.8%) in analysis of adequate samples positive for the
-globin gene (10). A systematic review showed that the HPV
detection rate from urine samples was less than 7%, although
higher HPV-positive rates were observed in samples scraped from
the male external genitalia, suggesting that urine may not be suit-
TABLE 2 Type-specific frequency of HPV in urine samplesa
HPV type
No. (%) of samples
Urethritis group Control group
High risk
HPV 16 6 (20.0) ND
HPV 18 2 (6.7) ND
HPV 31 1 (3.3) ND
HPV 33 2 (6.7) ND
HPV 39 1 (3.3) ND
HPV 52 1 (3.3) ND
HPV 58 4 (13.3) ND
HPV 59 2 (6.7) ND
HPV 68 1 (3.3) ND
Risk undetermined ND ND
HPV 66 ND 1 (20.0)
HPV 53 1 (3.3) ND
HPV 81 1 (3.3) ND
Low risk
HPV 6 2 (6.7) 1 (20.0)
HPV 11 1 (6.7) ND
HPV 42 1 (6.7) ND
Unknown 5 (16.6) 3 (60.0)
a HPV, human papillomavirus; ND, not detected.
FIG 1 Cytological findings of HPV-positive samples. (A) Koilocytosis. (B) Dyskeratocytosis. (C) Binucleate cells. (D) Mildly atypical transitional cells.
HPV Detection in Urine by Liquid-Based Urine Cytology
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able for detection of HPV (9). Our study also demonstrated a
lower detection rate of -globin in urine sediment samples (22).
The-globin gene was detected in only 65%of the urine sediment
samples but in 89% of scraped cell samples from the penis or in
93% of those from the urethra (22).
LBC is widely used for uterine cervical cancer screening in
women, as cell morphology is well preserved in LBC for a long
time (2). Furthermore, cell quantity on the slides can be manipu-
lated for LBC samples in the laboratory. LBC generally has good
sensitivity for diagnosis of high-grade cervical intraepithelial neo-
plasia or squamous cell carcinoma in the screening of cervical
cancer (13, 17), although its use in such screening is still contro-
versial (5). The most useful application for LBC is analysis of var-
ious molecular markers. LBC specimens are used for immunohis-
tochemical analysis of expression of some proteins or genes and
for gene detection of variousmicroorganisms as diagnostic aids or
for identifying causative agents. LBC is not commonly used for
urinary tract cytology. Piaton et al compared the conventional and
LBC tests (ThinPrep processing) in urine cytopathology and con-
cluded that conventional methods remained appropriate for uri-
nary cytology testing but that LBCwasmore suitable for cytology-
based molecular studies (18). PCR analysis is most commonly
used for various laboratory tests due to its high sensitivity and ease
of performance in any laboratory. However, the -globin detec-
tion rate is low in urine samples compared with rubbed cell sam-
ples in PCR analysis. Urine samples may contain some inhibitors
of PCR amplification, such as salts, minerals, or other as-yet-
unknown inhibitors (4). Therefore, some additional procedures
are necessary to remove such substances fromDNA samples from
urine sediment in PCR-based analysis. In the present study, only
cellular pellets of urine samples were preserved in the solution
when liquid-based cytology was used immediately after collecting
the samples from the patients, which may have contributed to the
removal of salts and minerals from the solvent and to good pres-
ervation of the urinary cellular pellet.
Cell numbers in urine sediment are generally limited in compar-
ison with scraped cell samples collected from the urinary tract. An
additional advantage of LB-URC is that cell quantity can be manip-
ulated to the required levels in the laboratory.However, cell numbers
were not sufficient for Papanicolaou testing and ISH analysis in the
present study. Samples of only 15ml of urine were used for the anal-
ysis. Although further trials are needed, it may be possible to over-
come this issue by collection of larger volumes of urine samples.
HPV prevalence in urine samples from urethritis patients was
high in the present study, whereas it was significant lower (3.4%)
in controls, which is consistentwith results reported previously (9,
10). The precise reason for the high prevalence of HPV infection
in the urinary tract among men with urethritis is not yet clear. A
possible explanation is that inflammation of the urinary tract may
induce cell exfoliation, which leads to easier detection of asymp-
tomatic HPV infection (11). Alternatively, urethritis itself may
increase the risk of HPV infection in the urinary tract. HPV infec-
tion requires the availability of a basal layer cell and usually occurs
in microlesions of skin or mucosa (30). Thus, microinjury to the
urothelium caused by urethritismay allowHPV to access the basal
cells of the urothelium, which is necessary for the establishment of
HPV infection. Indeed, it was reported previously that N. gonor-
rhoeae infection was an independent risk factor for HPV infection
in men with urethritis (25). In particular, gonococcal urethritis
can induce severe inflammation in the urethra.We also found that
the prevalence of HPV was significantly higher in patients with
GU who had more severe inflammation in the urethra than in
those with urethritis caused by other microorganisms, such as C.
trachomatis,Mycoplasma spp., andUreaplasma spp. Another pos-
sibility is that men with urethritis are generally a high-risk group
for STIs, including HPV infection (16).
With regard to the distribution of HPV types, high-risk geno-
types were detected in 67% of HPV-positive samples, and the
FIG 2 In situ hybridization findings of high-risk HPV-positive samples. (A)HPVDNA signals were predominantly observed in the nuclei of squamous cells. (B)
HPV DNA signals were also observed in urothelial cells.
TABLE 3 Comparison of HPV, Mycoplasma spp., and Ureaplasma spp.
detection by urethritis typea
Sample category
No. (%) of samples
GU NGCU NGNCU Control
Adequate 17 23 98 150
HPV positive 8 (47.0) 3 (13.0) 18 (18.4) 5 (3.3)
M. genitalium positive 1 (5.9) 5 (21.7) 14 (14.2) 5 (3.3)
M. hominis positive 1 (5.9) 2 (8.7) 12 (12.2) 3 (2.0)
U. parvum positive 0 0 9 (9.2) 7 (4.7)
U. urealyticum positive 1 (5.9) 5 (21.7) 11 (11.2) 4 (2.7)
a HPV, human papillomavirus; GU, gonococcal urethritis; NGCU, nongonococcal
chlamydial urethritis; NGNCU, nongonococcal and nonchlamydial urethritis.
Kawaguchi et al.
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most common genotype was type 16 (20.0%), followed by type 58
(13.3%), which is consistent with our previous studies regarding
HPV prevalence in the penis and urethra of men with urethritis
(22). Both HPV 52 and HPV 58 are common HPV types among
young Japanese women, and the distribution of HPV types de-
tected in the urine of men with urethritis was approximately sim-
ilar to that in the uterine cervix of Japanese women (3). HPV types
70, 72, 84, and 91 were also detected in samples from the Japanese
female cervix as unusualHPV types, andunknownHPV types that
might have been classified as undetermined in the present study
may have included these HPV types (3, 20).
M. genitalium,M.hominis,U. urealyticum, andU. parvumhave
been detected in patients with urethritis. M. genitalium and U.
urealyticum are thought to be especially important pathogens of
nongonococcal urethritis (NGU) (6, 7). On the other hand, U.
parvum andM. hominis are less common pathogens for male ure-
thritis, although these microorganisms have been reported as im-
portant antecedents of preterm birth in women (1, 8). In the pres-
ent study, the prevalence rates of M. genitalium, M. hominis, and
U. urealyticumwere significantly higher in urethritis patients than
in controls and were higher in NGNCU patients, suggesting that
species of bacteria other than U. parvum are likely to be the caus-
ative agents of NGNCU. Deguchi and Maeda reported that M.
genitalium and U. urealyticum were significantly more prevalent
in patients withNGNCUcompared to healthymen in Japan based
on analysis of first-voided urine specimens (6). Previous reports
also suggested that the prevalence rates of M. genitalium and U
urealyticum in men with NGNCU were significantly higher than
those inmen without urethritis, whereas there were no significant
differences in the prevalence rates of M. hominis and U. parvum
between the two groups (6, 7). However, the present results
showed that the prevalence of M. hominis was also significantly
higher in men with urethritis than in controls. One possible rea-
son for this discrepancy in the results is that we recovered urothe-
lial cells from the urinary bladder, which may be infected with
HPV, by collecting midstream urine specimens (24). In fact, a
previous study demonstrated that M. hominis was detected in
57.2%of the bladdermucosa specimens obtained from60patients
with leukoplakia and concluded thatM. hominis could frequently
infect the bladder mucosa (15). The numbers of subjects in this
study were too small to allow us to draw definitive conclusions
regarding the causative role ofM. hominis, and further studies are
required to investigate this hypothesis.
It is important to determine whether HPV plays a causative
role in the development of tumors in the urinary tract. Therefore,
we performed ISH analysis for HPV DNA by the use of LB-URC
samples to confirm the localization of high-risk HPV DNA in the
urothelial epithelium. Of 19 high-risk HPV-positive samples,
high-risk HPV DNA signals were successfully observed in some
squamous cells (Fig. 2A) and transitional cells (Fig. 2B) in three
HPV-positive cases. These observations suggest that HPV can in-
fect both squamous and transitional cells in the urinary tract, in-
cluding the urethra and urinary bladder. Papanicolaou test results
also demonstrated that some morphological changes of cells re-
lated to HPV infection occurred in 20.7% of the HPV-positive
samples, suggesting that HPV could replicate in some urothelial
cells. Furthermore, we reported previously that HPV is associated
with the development of inverted papilloma and low-grade can-
cers in the bladder (23, 24). Further studies to clarify the natural
history of urinary HPV infection are needed to investigate the
associations between HPV infection and the development of var-
ious tumors of the urinary tract.
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